Skip to main content

Published locations for PACIFIC: Durvalumab extends PFS in stage 3 NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. PACIFIC: Durvalumab extends PFS in stage 3 NSCLC

User login

  • Reset your password
  • /content/pacific-durvalumab-extends-pfs-stage-3-nsclc
  • /oncologypractice/article/146692/immuno-oncology/pacific-durvalumab-extends-pfs-stage-3-nsclc
  • /node/155702/article/146692/immuno-oncology/pacific-durvalumab-extends-pfs-stage-3-nsclc
  • /hematology-oncology/article/146692/immuno-oncology/pacific-durvalumab-extends-pfs-stage-3-nsclc
  • /chestphysician/article/146692/immuno-oncology/pacific-durvalumab-extends-pfs-stage-3-nsclc